InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Camille L Bedrosian, Chief Medical Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $1.5M, reported from Sep 1, 21 to Mar 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 26 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 6.5K | $14.58 | $94K |
| Dec 1, 25 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 6.6K | $14.35 | $94K |
| Sep 30, 25 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 12.0K | $14.58 | $176K |
| Mar 31, 25 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 12.4K | $3.47 | $43K |
| Dec 2, 24 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 5.4K | $5.54 | $30K |
| Sep 30, 24 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 11.4K | $3.20 | $37K |
| Mar 1, 23 | RAREUltragenyx Pharmaceutical Inc. | SELL | 3.9K | $45.25 | $176K |
| Mar 1, 22 | RAREUltragenyx Pharmaceutical Inc. | SELL | 2.8K | $66.62 | $188K |
| Jan 30, 22 | RAREUltragenyx Pharmaceutical Inc. | SELL | 1.7K | $66.30 | $110K |
| Oct 14, 21 | RAREUltragenyx Pharmaceutical Inc. | SELL | 359 | $81.14 | $29K |
| Sep 2, 21 | RAREUltragenyx Pharmaceutical Inc. | SELL | 2.5K | $100.18 | $250K |
| Sep 1, 21 | RAREUltragenyx Pharmaceutical Inc. | SELL | 2.5K | $100.03 | $250K |